openPR Logo
Press release

Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031

Neuropathic Pain Market is expected to undergo a CAGR of 9.2%

Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.

Market Overview

Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind of sensations, and may be accompanied by numbness or tingling. Conditions such as diabetes, nerve injury, and certain diseases can lead to neuropathic pain, which can be challenging to manage.            

Explore Further Details about This Research Neuropathic Pain Market Report

Global Neuropathic Pain Market Dynamics


Increasing Prevalence in  Aging Population

With the aging global population, the incidence of conditions associated with neuropathic pain, such as neuropathy, rises. This demographic shift fuels a greater demand for effective neuropathic pain management solutions, reflecting the need for comprehensive healthcare strategies to address the challenges of an aging society.

Government Initiatives for Neuropathic Pain Treatments

Supportive regulatory frameworks and expedited approval processes for neuropathic pain treatments foster innovation and research and development investment. This encourages pharmaceutical companies to develop new therapies, driving market growth by ensuring timely access to effective treatments and expanding the range of options available to patients suffering from neuropathic pain.


Patient-Centric Care for Effective Result

The shift towards patient-centric care and personalized medicine in neuropathic pain management fosters tailored treatment approaches. Through prioritizing individual patient needs and preferences, healthcare providers develop more effective and holistic strategies, improving patient outcomes and satisfaction in addressing the complexities of neuropathic pain

Rising Chronic Pain Management Programs

The growing emphasis on comprehensive chronic pain management programs, integrating interdisciplinary approaches and holistic interventions, caters to the multifaceted nature of neuropathic pain. This trend propels demand for associated products and services, reflecting a shift towards more effective and better solutions in addressing neuropathic pain. 

Some of the major players operating in the global neuropathic pain market are:

Lilly (U.S.)
Astellas Pharma Inc. (Japan)
Biogen (U.S.)
Cirtec (U.S.)
Integer Holdings Corporation (U.S.)
Braun SE  (Germany)
Medtronic (Ireland)
Abbott (U.S.)
Boston Scientific Corporation (U.S.)
OMRON Healthcare Co., Ltd. (Japan)
electroCore, Inc. (U.S.)
Polar Medical Ltd (U.K.)
SunMED Medical  (U.S.)
NeuroMetrix, Inc. (U.S.)

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Neuropathic Pain MarketSize, Share, Size & Forecast by different segment | 2023-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by segment with their sub-segments and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis

Key questions answered in the Neuropathic Pain Market are: 

What is Neuropathic Pain Market?
What was the Neuropathic Pain Market size in 2022?
What are the different segments of the Neuropathic Pain Market?
What growth strategies are the players considering to increase their presence in Neuropathic Pain Market?
What are the upcoming industry applications and trends for the Neuropathic Pain Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Neuropathic Pain Market?
What major challenges could the Neuropathic Pain Market face in the future?
What segments are covered in the Neuropathic Pain Market?
Who are the leading companies and what are their portfolios in Neuropathic Pain Market?
What segments are covered in the Neuropathic Pain Market?
Who are the key players in the Neuropathic Pain Market?

Browse Related Reports:

Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031 here

News-ID: 3473550 • Views:

More Releases from Data Bridge Market Research

Catalyst Fertilizers for Nitrogenous Fertilizer Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
Catalyst Fertilizers for Nitrogenous Fertilizer Market Size, Share, Trends, Key …
Global Catalyst Fertilizers For Nitrogenous Fertilizer Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Catalyst Fertilizers For Nitrogenous Fertilizer market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the
Smart Card in Government Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
Smart Card in Government Market Size, Share, Trends, Key Drivers, Demand and Opp …
Data Bridge Market research has recently issued comprehensive industry research on Global Smart Card in Government Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. Besides, Smart Card in Government market report studies market growth opportunities and restraining factors. The geographical division of this market analysis report offers data that gives an idea of the revenue of the companies and sales figures of the market
Bovine-Based Collagen for Biomedical Applications Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Bovine-Based Collagen for Biomedical Applications Market Size, Share, Trends, Ke …
Global Bovine Based Collagen For Biomedical Applications Market study by Data Bridge Market Research provides details about the market dynamics affecting the Bovine Based Collagen For Biomedical Applications market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Bovine Based Collagen For Biomedical Applications market analysis report is the high quality report having in-depth market research
Heat-Treated Steel Plates Market Size, Share, Trends, Opportunities, Key Drivers …
Heat Treated Steel Plates Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market

All 5 Releases

More Releases for Neuropathic

Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022 Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End. Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would
Neuropathic Pain Market: Global Industry Demand, Market Future 2028
Neuropathic Pain Market “Neuropathic Pain-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Neuropathic Pain epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028. Our epidemiology services include: • Incidence and prevalence • Diagnosis rate, treatment rate and mortality patterns • Epidemiology-based forecasting and disease trends • Size of different patient segments in a
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Neuropathic Pain Market Intelligence Report Offers Growth Prospects
Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The